| Dr Josette L Chamberlain, MD | |
|
163 Van Buren Rd, Caribou, ME 04736-3567 | |
| (207) 498-6921 | |
| (207) 498-1697 |
| Full Name | Dr Josette L Chamberlain |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 163 Van Buren Rd, Caribou, Maine |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720008840 | NPI | - | NPPES |
| 02475 | Other | ME | ATENA-NON |
| 12/5/2006 | Other | ME | CIGNA |
| 291380099 | Medicaid | ME | |
| 5626631 | Other | ME | ATENA-HMO |
| 2426734 06 | Other | ME | UNITED HEALTH CARE |
| 4/25/2007 | Other | ME | HEALTHNET |
| 11/20/2006 | Other | ME | HARVARD PILGRIM |
| 10/16/2006 | Other | ME | MARTINS POINT |
| 8/4/2006 | Other | ME | BENEFIT SERVICES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 015327 (Maine) | Primary |
| Entity Name | Pines Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942277819 PECOS PAC ID: 0749275113 Enrollment ID: O20040823001052 |
News Archive
Misonix, Inc., a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, has entered into a new, three year distribution agreement with Xenith, LLC, based in Dubai, UAE, for the distribution of the SonaStar(TM) Ultrasonic Surgical Aspirator, the BoneScalpel(TM) Ultrasonic Bone Cutter, and the SonicOne® Ultrasonic Wound Debrider.
Maike Sander, MD, associate professor of pediatrics and cellular & molecular medicine at the University of California, San Diego School of Medicine has been awarded nearly $5 million by the Beta Cell Biology Consortium (BCBC) to lead an interdisciplinary team in cell therapy research for type 1 diabetes.
A team of Scripps Research scientists has created a new analog to DNA that assembles and disassembles itself without the need for enzymes. Because the new system comprises components that might reasonably be expected in a primordial world, the new chemical system could answer questions about how life could emerge.
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, is reporting Pfizer Inc. has announced that it has decided to discontinue the late-stage study of its lung cancer candidate figitumumab (CP-751,871) while Novelos' pivotal Phase 3 trial, with a primary efficacy endpoint of improvement in median overall survival, continues across approximately 12 countries and 100 clinical sites.
A survey of 1,812 patients with moderate-to-severe asthma revealed that the disease was not controlled in 55 percent, despite the fact that most had health insurance and visited their health care providers regularly.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Josette L Chamberlain, MD Po Box 40, Caribou, ME 04736-0040 Ph: (207) 498-2359 | Dr Josette L Chamberlain, MD 163 Van Buren Rd, Caribou, ME 04736-3567 Ph: (207) 498-6921 |
News Archive
Misonix, Inc., a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, has entered into a new, three year distribution agreement with Xenith, LLC, based in Dubai, UAE, for the distribution of the SonaStar(TM) Ultrasonic Surgical Aspirator, the BoneScalpel(TM) Ultrasonic Bone Cutter, and the SonicOne® Ultrasonic Wound Debrider.
Maike Sander, MD, associate professor of pediatrics and cellular & molecular medicine at the University of California, San Diego School of Medicine has been awarded nearly $5 million by the Beta Cell Biology Consortium (BCBC) to lead an interdisciplinary team in cell therapy research for type 1 diabetes.
A team of Scripps Research scientists has created a new analog to DNA that assembles and disassembles itself without the need for enzymes. Because the new system comprises components that might reasonably be expected in a primordial world, the new chemical system could answer questions about how life could emerge.
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, is reporting Pfizer Inc. has announced that it has decided to discontinue the late-stage study of its lung cancer candidate figitumumab (CP-751,871) while Novelos' pivotal Phase 3 trial, with a primary efficacy endpoint of improvement in median overall survival, continues across approximately 12 countries and 100 clinical sites.
A survey of 1,812 patients with moderate-to-severe asthma revealed that the disease was not controlled in 55 percent, despite the fact that most had health insurance and visited their health care providers regularly.
› Verified 2 days ago
Regen A Gallagher, DO Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 163 Van Buren Rd, Caribou, ME 04736 Phone: 207-498-6921 Fax: 207-498-1392 | |
Markyia Nichols, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 163 Van Buren Rd, Caribou, ME 04736 Phone: 207-498-2359 Fax: 207-498-3947 | |
Brian Wall, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 163 Van Buren Rd, Caribou, ME 04736 Phone: 207-498-6921 Fax: 207-498-1392 | |
Dr. Rashmi Bawa, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 163 Van Buren Rd Ste 1, Caribou, ME 04736 Phone: 207-498-2448 Fax: 207-498-2483 |